Financing: I saved the best I have for you

Plattform Life Sciences Interview with Dr Michael Thormann, CEO, Origenis

Together with the investor Kleiner Perkins, Origenis GmbH founded the company Neuron23 in the US in 2018. How did this come about and how does Origenis benefit from it? And is this type of spin-off a model that could be repeated?

Life-Sciences-4-2023-Thormann-goingpublic.pdf

PDF herunterladen • 341KB

Plattform Life Sciences: spoke to Origenis CEO Dr Michael Thormann about this.